Overview

Thorough QT Study of Intravenous Amisulpride

Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
Randomised, single-dose, crossover, placebo-controlled study to see if intravenous amisulpride has any effect on the heart rhythm, in particular the QT interval, in healthy adult volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Acacia Pharma Ltd
Treatments:
Amisulpride
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Sulpiride
Sultopride